Inquirer on MSN6m
FDA OKs painkiller designed to cut opioids-linked addiction risk
WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
abc7NY31m
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Hays Post1h
Local pharmacies closings across state for advocacy day; learn why, see where
Independent pharmacies across Kansas will close on Wednesday, Feb.5, for a day of advocacy to raise awareness of what they ...
Bristol-Myers Squibb: Too Valuable Not To Hold This Pharma Gem, But Debt Challenges Remain
Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...
Europe to review safety data for Eisai-Biogen Alzheimer's drug
The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's ...
Knowridge2h
This drug protects heart and kidneys in type 2 diabetes
The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...
NVS Earnings: Entresto Drugmaker Novartis Tops Estimates as Patent Expiry Looms
Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...